JACC: CardioOncology
Издатель: Elsevier · ISSN 2666-0873 · 46 статей
- Cerebrovascular Accident Risk in Survivors of Head and Neck Cancer: JACC CardioOncology State-of-the-Art Review
- Cardiovascular Toxicity of Antibody-Drug Conjugates in Breast Cancer: Current Evidence and Evolving Considerations: JACC: CardioOncology Primer
- A Simple Clinical Risk Score to Improve Prediction of Anthracycline-Induced Cardiotoxicity
- The Quest for a Safer Use of Anthracyclines Continues: Risk Prediction of Clinical Cardiotoxicity
- Hemoglobin Decline After Oral Anticoagulation Initiation and Subsequent Cancer Detection in Patients With Atrial Fibrillation
- Hemoglobin Decline and Occult Cancer After OAC Initiation: “No Smoke Without Fire?”
- Cardiovascular-Kidney-Metabolic Syndrome Staging and Cancer Risk: Insights From Proteomic and Metabolomic Mediators
- The Cardiometabolic-to-Cancer Axis: Molecular Insights From Cardio-Kidney-Metabolic Syndrome Staging
- Divergent Effects of GnRH Agonist and GnRH Antagonist Treatment on Platelet Activity and Transcriptome
- Do Platelets Explain Why GnRH Antagonists Are Potentially Safer From a Cardiovascular Perspective?
- Sacubitril/Valsartan in Anthracycline-Treated Patients: A Systematic Review and Meta-Analysis of Available Evidence
- Sacubitril/Valsartan and Right Ventricular and Diastolic Function During Breast Cancer Therapy
- A Clinically Applicable Conversion Formula Between NT-proBNP and BNP in Light-Chain Amyloidosis
- Statin Use Attenuates Leuprolide-Associated Coronary Atherosclerosis Progression: A Secondary Analysis of the REVELUTION Trial
- Polygenic Risk Scores for Cardiovascular Risk Prediction in Breast Cancer Survivors: Implications for Asian Populations
- Reply: Polygenic Risk Scores for Cardiovascular Disease in Breast Cancer Survivors: Implications for Asian Populations
- Refining the Prognostic Interpretation of Myocardial PD-L1 Expression in ICI-Associated Myocarditis
- Reply: Refining the Prognostic Interpretation of Myocardial PD-L1 Expression in ICI-Associated Myocarditis
- When “Uptake” Is Organelle Biology: Derisking CRISPR Anthracycline Cardiotoxicity Screens
- Reply: Biochemical Remission and Residual Cardiac Abnormalities in AL Amyloidosis
- Biochemical Remission and Residual Cardiac Abnormalities in AL Amyloidosis
- Identifying Patients With Prostate Cancer Who Benefit Most From Routine Cardiovascular Specialist Referral
- Real-World Cardiotoxicity of Biosimilar versus Reference Trastuzumab in Early HER2-Positive Breast Cancer
- Cardiovascular Considerations of JAK Inhibitors in Patients With Hematologic Malignancies: JACC CardioOncology Primer
- Editorial Board
- Immune Pathways in Doxorubicin Cardiotoxicity: A Cardio-Immunology Perspective: JACC CardioOncology State-of-the-Art Review
- Immune Responses in Checkpoint Inhibitor–Associated Cardiovascular Immune–Related Adverse Events: JACC: CardioOncology State-of-the-Art Review
- Management and Surveillance of Immune Checkpoint Inhibitor Myocarditis: Managing the Aftermath: JACC CardioOncology State-of-the-Art Review
- Rechallenge After Immune Checkpoint Inhibitors Myocarditis: Evidence and a Practical Framework: JACC CardioOncology Primer
- Long-Term Cardiovascular Care After Cytokine Release Syndrome: JACC CardioOncology Primer